EUROGIN CONGRESS 2027

Description

The EUROGIN Congress is the world's leading international multidisciplinary conference dedicated to Human Papillomavirus (HPV) and related cancers. It serves as a premier platform for clinicians, researchers, and public health experts to share the latest scientific breakthroughs, clinical trials, and epidemiological data. The event focuses on translating scientific research into clinical practice and public health strategies, covering topics such as screening, vaccination, diagnostic testing, and the management of HPV-induced diseases including cervical, anal, and oropharyngeal cancers.

Exhibits

Diagnostic laboratories, pharmaceutical companies specializing in vaccines, medical device manufacturers for colposcopy, and molecular biology technology providers.

Activities

Scientific sessions, keynote lectures, oral communications, poster presentations, clinical workshops, and satellite symposia focusing on HPV prevention.

Speakers

Leading global oncologists, virologists, epidemiologists, gynecologists, and public health officials from organizations like the WHO and international research institutes.

Demos

Hands-on workshops for colposcopy techniques, demonstrations of new molecular screening assays, and digital health tools for cervical cancer screening programs.

Accessibility

The venue for 2027 is typically a major European convention center. From the nearest international airport, use express train services or airport shuttles to reach the city center. Local metro and tram networks provide direct access to the convention site. Driving directions usually involve following major ring roads toward the city's primary exhibition district.

Exhibitor Count

50

Expected Attendance

2500

You must be logged in to comment on this event.